78th Scientific Sessions Advance Program - 27

*	 Alpha Cells-New Sources of Beta
Cells?
A Hepatic-Islet-Alpha-Cell Axis
Integrates Amino Acid Availability
with Alpha-Cell Mass
Danielle Dean, PhD
Alpha-Cell Transdifferentiation
Kenichiro Furuyama, MD, PhD
Regulation of Alpha-Cell Mass and
Function by Nutrient Signaling
Ernesto Bernal-Mizrachi, MD
Transcriptional Control of AlphaCell Fate
Takaaki Matsuoka, MD, PhD
oral Presentations

mondAy, JUne 25, 2018
8:00 a.m.-10:00 a.m.
Symposia
*	 Role of the Kidney in Heart Health
Natural History of Nephropathy
and Associated Cardiovascular Risk
Julia Scialla, MD
Sodium-Hydrogen Exchange and
the Cardiorenal Axis
Julie A. Lovshin, MD, PhD
Impact of Tubuloglomerular
Feedback
Christopher T. Chan, MD, FRCPC
Cardiovascular Risk Reduction in
the Patient with Nephropathy
Janani Rangaswami, MD, FACP
*	 Intervening in the Lived
Experiences and Social Context of
Those with Diabetes
Understanding the Social Context
of Managing Diabetes-What's Life
Really Like?
Evan A. Los, MD
Intervention Targeting the
Social Determinants of
Health in Youth with Repeat
Diabetic Ketoacidosis-Novel
Interventions in Children's
Healthcare (NICH) Works
Lena Teplitsky, MPH
Integrating Social and Behavioral
Interventions for Diabetes in
Primary Care
Danielle M. Hessler, PhD
Using the Electronic Medical
Record with Patient-Reported
Outcomes for Social Determinants
of Health Screening and Resource
Linkage in Diabetes Care
Erika Cottrell, PhD, MPP

ORLANDO, FL | JUNE 22 - 26, 2018

*	 Who Do You Think You Are?
Heterogeneity of Obesity and
Gestational Diabetes Mellitus
Heterogeneity of Gestational
Diabetes-Physiologic and Genetic
Characterization
Marie-France Hivert, MD
Heterogeneity in Gestational
Diabetes Mellitus-A View from
the Beta Cell
Thomas A. Buchanan, MD
Metabolic Heterogeneity in Obese
Pregnancies-Looks Can Be
Deceiving
Linda A. Barbour, MD, MSPH, FACP
Treatment of Gestational Diabetes
Mellitus Based on Underlying
Pathophysiology
Maisa N. Feghali, MD
*	 Type 2 Diabetes in Youth-
Update on the Current State of
Knowledge on Complications
Natural History of Type 2 Diabetes
Mellitus in Youth-Different than in
Adults?
Fida Bacha, MD
Cardiovascular Disease Risk
Factors in Youth with Type 2
Diabetes Mellitus-Time to
Be More Aggressive in the
Management?
Amy S. Shah, MD
Microvascular Complications
in Youth with Type 2 Diabetes
Mellitus-How Common Are They
and When Do We Treat?
Amy K. Mottl, MD
Psychosocial and Behavioral SelfCare Challenges in Youth with
Type 2 Diabetes Mellitus-The Not
So Hidden Iceberg
Elizabeth M. Venditti, PhD
*	 Effectiveness of Telemedicine in
Underserved Communities
Project Extension for Community
Healthcare Outcomes (ECHO)-
Diabetes Education and Training
Evan Klass, MD
Success of Telehealth Eye Care in
Indian Health Service
Mark B. Horton, OD, MD
Telemedicine Care in Rural
Communities
Michele Heisler, MD, MPA
eHealth for Diabetes Care in Latino
Communities
A. Enrique Caballero, MD

*	 Clinical Trials for Type 1
Diabetes-Current, Emerging, and
Novel
What We Have Learned and Plan to
Learn from TrialNet Studies
Manuela Battaglia, PhD
Increasing the Pace of Research-
Novel Clinical Trial Designs
Jeffrey Krischer, PhD
Combination Immunotherapy for
Type 1 Diabetes-The TrialNet ATG/
GCSF Study
Michael Haller, MD
From Mechanism to Clinical Trial-
Methyldopa for Type 1 Diabetes
Prevention
Aaron Michels, MD
*	 Recognition of Depression,
Diabetes, and Dementia-
Resetting Clinical Priorities
Neuroimaging and Neuromodulation in Obesity and Type 2
Diabetes                 
Maria A. Guzzardi, PhD
Insulin Resistance and Cognition
  Sophia Frangou, MD, MSc, PhD,
FRCPsych
Research Perspective of Diabetes
and Depression-The Neuroendocrine Link
Sherita Golden, MD, MHS
What Is the Role of Diabetes
Treatments in the Treatment of
Psychiatric Disorders?
Roger S. McIntyre, MD, FRCPC
*	 Metabolism and the Beta Cell
Disallowed Genes
Timothy Pullen, PhD
Glucose Metabolism
Richard G. Kibbey, MD, PhD
Regulation of Islet Beta-Cell
Glucose Cycling by IGRP/G6PC2
Richard M. O'Brien, PhD
Functional and Metabolomic
Consequences of KATP Channel
Inactivation in Human Islets
Diva D. De León-Crutchlow, MD,
MSCE
oral Presentations

Speakers and presentation titles are subject to change.

27



Table of Contents for the Digital Edition of 78th Scientific Sessions Advance Program

78th Scientific Sessions Advance Program - 1
78th Scientific Sessions Advance Program - 2
78th Scientific Sessions Advance Program - 3
78th Scientific Sessions Advance Program - 4
78th Scientific Sessions Advance Program - 5
78th Scientific Sessions Advance Program - 6
78th Scientific Sessions Advance Program - 7
78th Scientific Sessions Advance Program - 8
78th Scientific Sessions Advance Program - 9
78th Scientific Sessions Advance Program - 10
78th Scientific Sessions Advance Program - 11
78th Scientific Sessions Advance Program - 12
78th Scientific Sessions Advance Program - 13
78th Scientific Sessions Advance Program - 14
78th Scientific Sessions Advance Program - 15
78th Scientific Sessions Advance Program - 16
78th Scientific Sessions Advance Program - 17
78th Scientific Sessions Advance Program - 18
78th Scientific Sessions Advance Program - 19
78th Scientific Sessions Advance Program - 20
78th Scientific Sessions Advance Program - 21
78th Scientific Sessions Advance Program - 22
78th Scientific Sessions Advance Program - 23
78th Scientific Sessions Advance Program - 24
78th Scientific Sessions Advance Program - 25
78th Scientific Sessions Advance Program - 26
78th Scientific Sessions Advance Program - 27
78th Scientific Sessions Advance Program - 28
78th Scientific Sessions Advance Program - 29
78th Scientific Sessions Advance Program - 30
78th Scientific Sessions Advance Program - 31
78th Scientific Sessions Advance Program - 32
https://www.nxtbookmedia.com